Archive | October, 2009

Not a Pretty Picture: Debt, Divorce, and Bankruptcy

30 October 2009 – 1:42 pm PST

Comments Off

Not a Pretty Picture: Debt, Divorce, and Bankruptcy

Those were the top named service requests reported by Pre-Paid Legal Services (NYSE: PPD) based on input from their participating law firms.  Pre-paid legal services provides specified legal services to their members.

Continue reading...

Rosetta Genomics’ Diagnostic Program Update (NASDAQ:ROSG)

30 October 2009 – 1:37 pm PST

Comments Off

Rosetta Genomics’ Diagnostic Program Update (NASDAQ:ROSG)

Rosetta Genomics (NASDAQ:ROSG) today announced an update regarding their colon cancer diagnostic program and said that Ayelet Chajut, Executive Vice President, R&D, Head of Molecular Biology will speak more about this program at the 6th International Conference on Circulating Nucleic Acids in Plasma and Serum (CNAPS-VI).

Continue reading...

Geron Will Re-initiate Clinical Trials (NASDAQ:GERN)

30 October 2009 – 1:22 pm PST

Comments Off

Geron Will Re-initiate Clinical Trials (NASDAQ:GERN)

Geron Corporation (NASDAQ:GERN) today announced that they have reached an agreements with the Food and Drug Administration to re-initiate clinical trials for spinal cord injury.

Continue reading...

BSD Medical’s Hyperthermia Therapy (NASDAQ:BSDM)

30 October 2009 – 12:25 pm PST

Comments Off

BSD Medical’s Hyperthermia Therapy (NASDAQ:BSDM)

BSD Medical Corporation (NASDAQ:BSDM) today announced that their published study results demonstrated improvement in the overall survival, tumor response rates, and local tumor control from the addition of hyperthermia therapy delivered through BSD-2000 Hyperthermia System. This therapy was delivered as a standard treatment regimen for the 45 patients suffering from high-risk bladder cancer.

Continue reading...

NavStar Technologies Fails To Meet Promises (PINK:NVSR)

30 October 2009 – 9:34 am PST

Comments Off

NavStar Technologies Fails To Meet Promises (PINK:NVSR)

It has been almost a month since NavStar Technologies Inc (PINK:NVSR) announced a “Major Breakthrough” in the Middle east on October 8, 2009. They anounced that “Details will be provided to shareholders in the next 5 to 7 days” on this “Major Breakthrough”. Now investors have been in the dark for 22 days and NavStar failed to [...]

Continue reading...

Depomed Q3 Financial Results (NASDAQ:DEPO)

30 October 2009 – 7:33 am PST

Comments Off

Depomed Q3 Financial Results (NASDAQ:DEPO)

Depomed, Inc (NASDAQ:DEPO) today reported financial results for the third quarter that ended on September 30, 2009.

Continue reading...

Dynavax with new HEPLISAV Data (NASDAQ:DVAX)

30 October 2009 – 7:15 am PST

Comments Off

Dynavax with new HEPLISAV Data (NASDAQ:DVAX)

In one of the most surprising news today, Dynavax Technologies Corporation (NASDAQ:DVAX) has announced that the first clinical data of their HEPLISAV has shown increase in the protection rate for chronic kidney disease patients. The data will be presented publicly in a poster session on Saturday, October 31, 2009 at the Annual Meeting of the Infectious [...]

Continue reading...

Celera and Medical Therapies (NASDAQ:CRA)

30 October 2009 – 7:00 am PST

Comments Off

Celera and Medical Therapies (NASDAQ:CRA)

On a late Thursday evening, Celera Corporation (NASDAQ:CRA) and Medical Therapies Limited have announced that they have entered an exclusive license agreement for the use of Medical Therapies’ midkine patent portfolio for the development of novel lung cancer diagnostics.

Continue reading...

Bioelectronics Answers Shareholder Questions (OTC:BIEL)

29 October 2009 – 9:44 am PST

View Comments

Bioelectronics Answers Shareholder Questions (OTC:BIEL)

Bioelectronics Corp (OTC:BIEL) answered many shareholder questions in a email from Joe Noel posted by MarselusWallace. These questions and answers from Joe Noel are not modified in any way and contains numerous typos as these answers took Mr. Noel a considerable amount of time and to edit the answers would cost him time he simply [...]

Continue reading...

CytRx’s Seeking Destruction Of Cancer Cells (NASDAQ:CYTR)

29 October 2009 – 9:38 am PST

Comments Off

CytRx’s Seeking Destruction Of Cancer Cells (NASDAQ:CYTR)

CytRx Corporation (NASDAQ:CYTR) has announced that a paper published in Gerontology journal concluded that molecular chaperone amplification may represent a significant strategy in the designing of anti-aging pharmaceuticals in the near future.

Continue reading...